ORIGINAL ARTICLE
Histopathological assessment of oral leukoplakia. Osteonectin as possible biomarker for further diagnostics
1
Oral Pathology Department, Faculty of Dentistry, Wroclaw Medical University, Wroclaw, Poland
2
Department and Clinic of Maxillofacial Surgery, Faculty of Dentistry, Wroclaw Medical University, Wroclaw, Poland
3
Department of Pathomorphology and Oncological Cytology, Faculty of Dentistry, Wroclaw Medical University, Wroclaw, Poland
Publication date: 2020-07-21
Pol J Pathol 2020;71(2):138-145
KEYWORDS
ABSTRACT
Clinical evaluation of oral leukoplakia (OL), confirmed by the histological evaluation of the suspected area, provides the gold standard for diagnostics of this pathology. The aim of present study was to encrypt the significance of the histopathological results (oral intraepithelial neoplasia – OIN, WHO 2005, Ljubljana classification systems) of OL. The usefulness of osteonectin as a biomarker of changes in the oral cavity epithelium was evaluated.
IRS Score to evaluate osteonectin (SPARC – secreted protein acidic and rich in cysteine) production in oral mucous tissues was modified, with the aim of adapting the diagnostic measurements to the OL cell environment. In total, 37 formalin-fixed, paraffin-embedded (FFPE) blocks from patients with clinically diagnosed OL, and 29 FFPE blocks from patients with OSCC were evaluated. The OIN and system from Ljubljana were compared, to adjudicate which was most compatible with WHO 2005 histopathological assessment.
Increased production of SPARC was observed, with the progression in severity of pathological changes in the oral mucosa, from simple hyperplasia, through dysplasia, to OSCC. The WHO 2005 and the OIN classification systems can be applied interchangeably.
IRS Score to evaluate osteonectin (SPARC – secreted protein acidic and rich in cysteine) production in oral mucous tissues was modified, with the aim of adapting the diagnostic measurements to the OL cell environment. In total, 37 formalin-fixed, paraffin-embedded (FFPE) blocks from patients with clinically diagnosed OL, and 29 FFPE blocks from patients with OSCC were evaluated. The OIN and system from Ljubljana were compared, to adjudicate which was most compatible with WHO 2005 histopathological assessment.
Increased production of SPARC was observed, with the progression in severity of pathological changes in the oral mucosa, from simple hyperplasia, through dysplasia, to OSCC. The WHO 2005 and the OIN classification systems can be applied interchangeably.
REFERENCES (25)
1.
Hassona Y, Scully C, Almangush A, et al. Oral potentially malignant disorders among dental patients: a pilot study in Jordan. Asian Pac J Cancer Prev 2014; 15: 10427-10431.
2.
Shearston K, Fateh B, Tai S, et al. Malignant Transformation Rate of Oral Leukoplakia in an Australian population. J Oral Pathol Med 2019; jop.12899.
3.
de Menezes RF, Bergmann A, Thuler LCS. Alcohol Consumption and Risk of Cancer: a Systematic Literature Review. Asian Pacific J Cancer Prev 2014; 14: 4965-4972.
4.
Silveira M, Dedivitis R, Queija D, Nascimento P. Quality of Life in Swallowing Disorders after Nonsurgical Treatment for Head and Neck Cancer. Int Arch Otorhinolaryngol 2014; 19: 046-054.
5.
Boffetta P, Ye W, Adami HO, et al. Risk of cancers of the lung, head and neck in patients hospitalized for alcoholism in Sweden. Br J Cancer 2001; 85: 678-682.
6.
Ang XM, Au PCK, Kwok K, et al. Quality of Life in Patients with Oral Leukoplakia. J Oral Pathol Med 2019; jop.12897.
7.
Malik UU, Zarina S, Pennington SR. Oral squamous cell carcinoma: Key clinical questions, biomarker discovery, and the role of proteomics. Arch Oral Biol 2016; 63: 53-65.
8.
Brouns ER, Baart JA, Bloemena E, et al. The relevance of uniform reporting in oral leukoplakia: Definition, certainty factor and staging based on experience with 275 patients. Med Oral Patol Oral Cir Bucal 2013; 18: e19-e26.
9.
Bouquot JE, Speight PM, Farthing PM. Epithelial dysplasia of the oral mucosa – diagnostic problems and prognostic features. Curr Diagnostic Pathol 2006; 12: 11-21.
10.
Jaber MA, Porter SR, Speight P, et al. Oral epithelial dysplasia: clinical characteristics of western European residents. Oral Oncol 2003; 39: 589-596.
11.
Martorell-Calatayud A, Botella-Estrada R, Bagán-Sebastián JV, et al. Oral Leukoplakia: Clinical, Histopathologic, and Molecular Features and Therapeutic Approach. Actas Dermo-Sifiliográficas (English Ed) 2009; 100: 669-684.
12.
Mello FW, Miguel AFP, Dutra KL, et al. Prevalence of oral potentially malignant disorders: A systematic review and meta-analysis. J Oral Pathol Med 2018; 47: 633-640.
13.
El-Naggar AK, Chan JKC, Rubin Grandis J, et al. International Agency for Research on Cancer. WHO Classification of Head and Neck Tumours. https://publications.iarc.fr/B.... Accessed July 3, 2019.
14.
Ranganathan K, Kavitha L. Oral epithelial dysplasia: Classifications and clinical relevance in risk assessment of oral potentially malignant disorders. J Oral Maxillofac Pathol 2019; 23: 19-27.
15.
Barnes L, Eveson JW, Reichart P (eds.). Pathology and Genetics of Head and Neck Tumours. Available at: http://publications.iarc.fr/Bo....
16.
Aquino G, Sabatino R, Cantile M, et al. Expression Analysis of SPARC/Osteonectin in Oral Squamous Cell Carcinoma Patients: From Saliva to Surgical Specimen. Biomed Res Int 2013; 2013: 1-9.
17.
Yamada T, Ohno S, Kitamura N, et al. SPARC is associated with carcinogenesis of oral squamous epithelium and consistent with cell competition. Med Mol Morphol 2015; 48: 129-137.
18.
Futyma K, Kubiatowski T, Rózyñska K, et al. Decreased osteonectin and fibronectin gene expression in endometrial cancer cancer as a prognostic marker. Ginekol Pol 2009; 80: 907-913.
19.
Trombetta JM, Bradshaw AD. SPARC/osteonectin functions to maintain homeostasis of the collagenous extracellular matrix in the periodontal ligament. J Histochem Cytochem 2010; 58: 871-879.
20.
Remmele W, Stegner HE. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe 1987; 8: 138-140.
21.
Wojciechowska U, Didkowska J. Zachorowania i zgony na nowotwory z³oœliwe w Polsce. Krajowy Rejestr Nowotworów Centrum Onkologii – Instytut Im. Marii Sk³odowskiej-Curie. Dostêpne na stronie: Http://Onkologia.Org.Pl/Raporty/ Dostêp z Dnia 03/07/2019. http://onkologia.org.pl/raport... [Accessed July 3, 2019].
22.
Warnakulasuriya S, Reibel J, Bouquot J, Dabelsteen E. Oral epithelial dysplasia classification systems: Predictive value, utility, weaknesses and scope for improvement. J Oral Pathol Med 2008; 37: 127-133.
23.
Küffer R, Lombardi T. Premalignant lesions of the oral mucosa. A discussion about the place of oral intraepithelial neoplasia (OIN). Oral Oncol 2002; 38: 125-130.
24.
van der Waal I. Oral leukoplakia, the ongoing discussion on definition and terminology. Med Oral Patol Oral Cir Bucal 2015; 20: e685-e692.
25.
Jing Y, Jin Y, Wang Y, et al. SPARC promotes the proliferation and metastasis of oral squamous cell carcinoma by PI3K/AKT/PDGFB/PDGFRβ axis. J Cell Physiol 2019; 10.1002/jcp.28205.
| eISSN: | 2084-9869 |
| ISSN: | 1233-9687 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
